Kimberley Young
More articles by Kimberley Young
-
Paris Hatzianastasiadis of Lumenis tells OT about the company’s pilot programme to bring dry eye treatments into optical practices
-
The first in a new family of contact lenses contains the amino acid tyrosine, aiming to correct vision as well as promoting the healthy development of the eye for children and young adults
-
The researchers believe the technology, which uses nanoparticles to deliver an RUNX1 inhibitor, could have applications in treating diseases relating to sight loss
-
The new agreement aids Positive Impact’s aims of building a ‘best in class’ dry eye portfolio, while supporting Eye Doctor’s expansion goals into the independent sector
-
The survey, organised in partnership with Johnson & Johnson Vision, seeks to understand how COVID-19 has affected contact lens practice and customer behaviour
-
The research centre suggests that optometrists ask patients about symptoms and offer advice for alleviating dry eye symptoms when wearing a face mask
-
Professor Farhad Hafezi, chief medical officer at the ELZA Institute, speaks to OT about the future of cross-linking and treating bacterial keratitis at the slit lamp
-
The Optical Confederation’s Domiciliary Eyecare Committee has produced guidance on meeting the eye care needs of vulnerable patients in the next stage of the pandemic
-
The pharmaceutical market for age-related macular degeneration will be driven by the entry of longer-acting therapies, according to analysts at GlobalData